VEGFA and pseudoxanthoma elasticum (inherited or acquired): To date, medical management of PXE is mostly symptomatic (intraocular anti-VEGF treatment; primary and secondary cardiovascular prevention) as no curative treatment options are available yet, warranting further research into the pathogenic mechanisms of this disorder.